| Ms Michelle Sheridan, LMFT | |
|
1836 Baldwin St, Jenison, MI 49428-8901 | |
| (616) 457-0016 | |
| (616) 457-1950 |
| Full Name | Ms Michelle Sheridan |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 1836 Baldwin St, Jenison, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750729828 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 4101006508 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Michelle Sheridan, LMFT 692 Goldenrod Ave, Holland, MI 49423-6857 Ph: (917) 327-3528 | Ms Michelle Sheridan, LMFT 1836 Baldwin St, Jenison, MI 49428-8901 Ph: (616) 457-0016 |
News Archive
The global market for cardiac rhythm management devices such as pacemakers and defibrillators is worth about $13 billion for 2015, according to Kalorama Information. The market research publisher said the market has benefited from the demand to move to a more mobile, wireless and efficient system both within major health facilities and in the home treatment markets. There is also an increasing trend to upgrade to more portable devices and devices which have added benefits such as MRI compatibility.
Surgical Hospital of Oklahoma, located in Oklahoma City, today announced that it has partnered with Surgical Care Affiliates (SCA), one of the country's largest providers of specialty surgical services.
A report from the U.N.'s International Fund for Agricultural Development found that approximately 350 million people living in rural areas have escaped extreme poverty over the past decade, but most of the world's poorest citizens continue to live in rural regions, the BBC reports (Melik, 12/6).
Researchers at the Vaccine and Gene Therapy Institute (VGTI) and the Oregon National Primate Research Center at Oregon Health & Science University have received a $3.5 million grant from the National Institutes of Health to develop new methods for vaccinating humans against human immunodeficiency virus (HIV), the virus that causes AIDS.
› Verified 9 days ago